Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA details Class I catheter recall over safety risk
The FDA first shared a warning about this issue back in April. Now, the agency has shared a critical update.
Advanced AI helps 3D imaging labs evolve with the times
“Technology grows and grows,” as one lab director explained. “Our job is to keep up with it and use it in the most efficient and effective way.”
New ways to predict TAVR outcomes for individual heart patients
As TAVR continues to gain popularity, researchers remain focused on discovering new ways to predict short- and long-term outcomes. One recent study, for example, explored the potential of AI-enabled imaging assessments. Another analysis focused on the CALLY index.
Stroke prevention devices for TAVR fail to make an impact
Cerebral embolic protection devices are "compelling," researchers wrote, but current data does not suggest they make a significant impact on patient outcomes.
Surgery still outperforms GLP-1 drugs in terms of heart health
Both treatment options are effective, but metabolic and bariatric surgery was linked to more significant cardiovascular risk reductions than GLP-1 medications.

Beacon Tip Centimeter Sizing Catheter FDA alert

FDA details Class I catheter recall over safety risk

The FDA first shared a warning about this issue back in April. Now, the agency has shared a critical update.

Kimberly Hatch, RT(R)(CT)(ARRT), technical director of 3D lab at Banner Health, explains the advances in advanced visualization software what is needed to build a comprehensive cardiac 3D imaging lab.

Advanced AI helps 3D imaging labs evolve with the times

“Technology grows and grows,” as one lab director explained. “Our job is to keep up with it and use it in the most efficient and effective way.”

New ways to predict TAVR outcomes for individual heart patients

As TAVR continues to gain popularity, researchers remain focused on discovering new ways to predict short- and long-term outcomes. One recent study, for example, explored the potential of AI-enabled imaging assessments. Another analysis focused on the CALLY index.

Stroke prevention devices for TAVR fail to make an impact

Cerebral embolic protection devices are "compelling," researchers wrote, but current data does not suggest they make a significant impact on patient outcomes.

doctor with overweight patient who may be treated with TAVR or surgery

Surgery still outperforms GLP-1 drugs in terms of heart health

Both treatment options are effective, but metabolic and bariatric surgery was linked to more significant cardiovascular risk reductions than GLP-1 medications.

cardiologists evaluating the human heart to provide a treatment strategy

Redo TAVR: Supra-annular, intra-annular valves linked to comparable outcomes

When a TAVR valve fails and that patient undergoes redo TAVR, are there benefits to choosing one device type over the other? The team behind a new study tracked multiple outcomes and identified specific factors that may help predict survival.

Johnson & Johnson to acquire Atraverse Medical

The move, once finalized, helps Johnson & Johnson add multiple FDA-approved technologies to its EP portfolio.

healthcare money economics dollar stethoscope acquire merger

Siemens Healthineers to receive $60M in federal funding for key cancer therapy

Photon flash therapy is an experimental treatment that delivers an ultrahigh dose rate of radiotherapy 100 times faster than currently available options.